Literature DB >> 4901383

Similarities between neurologic effects of L-dopa and of apomorphine.

G C Cotzias, P S Papavasiliou, C Fehling, B Kaufman, I Mena.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4901383     DOI： 10.1056/NEJM197001012820107

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  34 in total

Review 1.  Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?

Authors:  L Dépatie; S Lal
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

Review 2.  Pharmacological treatment of Parkinson's disease.

Authors:  A Münchau; K P Bhatia
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

3.  Cardiovascular reflexes in Parkinson's disease: effect of domperidone and apomorphine.

Authors:  M Merello; Z Pirtosek; S Bishop; A J Lees
Journal:  Clin Auton Res       Date:  1992-08       Impact factor: 4.435

4.  The clinical use of apomorphine in Parkinson's disease.

Authors:  M J Steiger; N P Quinn; C D Marsden
Journal:  J Neurol       Date:  1992-08       Impact factor: 4.849

Review 5.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

6.  Efficacy of sublingual apomorphine in Parkinson's disease.

Authors:  F Durif; D Deffond; M Tournilhac
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-12       Impact factor: 10.154

7.  Subcutaneous apomorphine in Parkinson's disease.

Authors:  K R Chaudhuri; C Clough
Journal:  BMJ       Date:  1998-02-28

8.  Apomorphine-Induced Immune Hemolytic Anemia.

Authors:  Begoña Venegas Pérez; Teresa Arquero Portero; María Soledad Sánchez Fernández; Cici Feliz Feliz; Javier Del Val Fernández; Pedro José García-Ruiz
Journal:  Mov Disord Clin Pract       Date:  2016-06-06

Review 9.  Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.

Authors:  Dirk Deleu; Yolande Hanssens; Margaret G Northway
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

10.  EEG sleep patterns in Parkinsonian patients treated with bromocryptine and L-dopa: a comparative study.

Authors:  J Vardi; H Glaubman; J Rabey; M Streifler
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.